Back to Search
Start Over
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
- Source :
-
Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Jan; Vol. 81 (1), pp. 143-145. Date of Electronic Publication: 2021 Sep 23. - Publication Year :
- 2022
-
Abstract
- Competing Interests: Competing interests: None declared.
- Subjects :
- Abatacept adverse effects
Administration, Intravenous
Aged
Antibodies, Monoclonal, Humanized adverse effects
B-Lymphocytes
Biological Products administration & dosage
Biological Products therapeutic use
Female
Hospitalization
Humans
Infliximab adverse effects
Male
Middle Aged
Patient Acuity
Risk Factors
Rituximab adverse effects
SARS-CoV-2
Antirheumatic Agents adverse effects
Arthritis drug therapy
Biological Products adverse effects
COVID-19 chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1468-2060
- Volume :
- 81
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Annals of the rheumatic diseases
- Publication Type :
- Report
- Accession number :
- 34556483
- Full Text :
- https://doi.org/10.1136/annrheumdis-2021-220549